Topics

Human medicines European public assessment report (EPAR): Olanzapine Glenmark, olanzapine, Schizophrenia,Bipolar Disorder, Date of authorisation: 03/12/2009, Revision: 13, Status: Authorised

13:43 EDT 1 Sep 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Olanzapine Glenmark, olanzapine, Schizophrenia,Bipolar Disorder, Date of authorisation: 03/12/2009, Revision: 13, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Olanzapine Glenmark, olanzapine, Schizophrenia,Bipolar Disorder, Date of authorisation: 03/12/2009, Revision: 13, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Olanzapine Glenmark, olanzapine, Schizophrenia,Bipolar Disorder, Date of authorisation: 03/12/2009, Revision: 13, Status: Authorised"

Quick Search

Relevant Topic

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...